Supplementary Fig. 2.

Treatment-related survival analysis of candidate 5 site-gene panel in TCGA, Beltran et al, and PROMOTE patient cohorts. (a) Treatment-related Kaplan-Meier survival analysis of candidate 5 site-gene panel in TCGA Gleason 7 and Gleason 8-9, demonstrating that therapeutic predictive ability of the identified 5 site-gene panel is independent of Gleason score. Log-rank p-values are indicated. (b) ROC analysis comparing TCGA-PRAD (group1) with Beltran et al (green) and PROMOTE (brown) patient cohorts. AUROC is indicated.